Drug Designing: Open Access : Citations & Metrics Report
Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.
Following are the list of articles that have cited the articles published in Drug Designing: Open Access.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 32 | 30 | 31 | 67 | 2 | 5 | 16 | 18 | 12 | 14 | 24 | 6 |
Research, Review articles and Editorials |
0 | 2 | 2 | 24 | 33 | 0 | 4 | 15 | 15 | 12 | 10 | 25 | 6 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
14 | 30 | 27 | 7 | 35 | 2 | 1 | 1 | 3 | 0 | 4 | 3 | 0 |
Conference proceedings |
0 | 5 | 5 | 0 | 0 | 0 | 124 | 81 | 41 | 56 | 0 | 0 | 58 |
Citations received as per Google Scholar, other indexing platforms and portals |
45 | 51 | 54 | 62 | 43 | 41 | 41 | 23 | 48 | 16 | 10 | 5 | 0 |
Journal total citations count | 456 |
Journal impact factor | 1.70 |
Journal 5 years impact factor | 1.5 |
Journal cite score | 1.57 |
Journal h-index | 9 |
Journal h-index since 2019 | 7 |
Important citations (297)
Nano drug delivery system - a mini review |
|
Approach antimicrobial, antioxidant and anti-inflammatory activity of hydroxychavicol on cancer cells |
|
Salinomycin and its derivatives - a new class of multiple-targeted "magic bullets". |
|
Drug re?positioning studies for novel hiv?1 inhibitors using binary qsar models and multi?target?driven in silico studies |
|
Computer-aided design of ligands at multiple protein targets for multifactorial diseases |
|
Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. |
|
A photoactivatable chemotherapeutic ru(ii) complex bearing bathocuproine ligand efficiently induces cell death in human malignant melanoma cells through a multi-mechanistic pathway |
|
Understanding the polypharmacological profiles of triple reuptake inhibitors by molecular simulation. |
|
Bioisosteric development of multitarget nonsteroidal anti-inflammatory drug-carbonic anhydrases inhibitor hybrids for the management of rheumatoid arthritis. |
|
discovery of ?-adrenergic receptors blocker-carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy. |
|
Kdr/vegfr-2 receptor tyrosine kinase inhibitors and 3d qsar (comfa and comsia) study |
|
Yasala ak, khan t. research & reviews: journal of medical and health sciences. 2016 |
|
Tripathi s. research and reviews: journal of pharmaceutics and nanotechnology. nanotechnology. 2016; 7:10. |
|
Biopolymer based nanomaterials in drug delivery systems: a review |
|
Effect of lignin on the release rate of acetylsalicylic acid tablets. |
|
Natural product-based nanoformulations for cancer therapy: opportunities and challenges |
|
Smart biopolymers and their biomedical applications |
|
Smart biopolymeric nanocarriers for drug delivery applications |
|
Recent advancement of biopolymers and their potential biomedical applications |
|
Formulation of novel chitosan guargum based hydrogels for sustained drug release of paracetamol. |
|